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Initially characterized for their roles in apoptosis, executioner caspases have emerged as important regula-
tors of an array of cellular activities. This is especially true in the nervous system, where sublethal caspase
activity has been implicated in axonal pathfinding and branching, axonal degeneration, dendrite pruning,
regeneration, long-term depression, and metaplasticity. Here we examine the roles of sublethal executioner
caspase activity in nervous system development and maintenance, consider the mechanisms that locally
activate and restrain these potential killers, and discuss how their activity be subverted in neurodegenerative
disease.The pioneering studies that led to the identification of CED3 as an
executioner caspase in Caenorhabditis elegans heralded an ex-
plosion of activity that established caspases and apoptosis as
crucial developmental effectors in essentially all metazoan spe-
cies (Putcha and Johnson, 2004; Yuan et al., 1993). In the last
quarter century, the biochemistry and biology of the caspase
family have been under intense study, and the roles of caspases
in developmental, injury-induced, and disease-associated cell
death have been well characterized (McIlwain et al., 2013). There
are 18 caspases present in mammals, but only a subset of these
function in the core pathways that mediate apoptosis. Termed
the apoptotic caspases, these are further categorized into initi-
ator caspases and executioner caspases. Initiator caspases
act as signal integrators that translate receptor- or sensor-based
cues into activation signals for the executioner caspases that
mediatemost of the proteolytic cleavages required to kill the cell.
The executioner caspases are very good at what they do. In
almost every cell, from worms to man, their destructive power
can be unleashed to kill the cell. However, over the last several
years, it has become clear that executioner caspases also carry
out a wide array of sublethal functions. Using such potent killers
for non-lethal tasks is a risky proposition, and mechanisms that
locally activate, target, and limit executioner caspase activity
play a key role, ensuring that caspase activity is kept in check.
Indeed, a primary function of caspase regulatory mechanisms
is to ensure that executioner caspases are employed in sublethal
settings.
Because executioner caspases are under tight temporal and
spatial control, their actions are particularly well suited for
neurons that must integrate local signals and then drive rapid
structural and morphological change in regions far from the
cell body and nucleus. In this review, we first examine cellular
settings in which roles for sublethal caspase roles have been es-
tablished, taking a phylogenetic view when possible, and then
focus on the roles of sublethal executioner caspase activity in
nervous system development, maintenance, and disease. Wethen discuss the mechanisms that regulate sublethal caspase
activity and close with future perspectives.
Executioner Caspase Activation Pathways
In mammals, the ultimate effectors of the cascade that drives the
apoptotic program are the executioner caspases 3, 6, and 7
(Fuentes-Prior and Salvesen, 2004). The executioner caspases
are zymogens that are activated by upstream initiator caspases
such as caspase-8 and caspase-9. After proteolytic cleavage,
the large (a) and small (b) subunits assemble into catalytically
active oligomers, with abb0a0 symmetry, that have two active
sites per complex. The accumulation of cleaved forms of an
executioner caspase is often considered a hallmark of an irre-
versible commitment to apoptosis, and cleavage-specific anti-
bodies that detect the active forms of caspase-3, -6, or -7 are
often used to identify apoptotic cells.
Two main pathways of executioner caspase activation have
been identified (Chowdhury et al., 2008; Li and Yuan, 2008).
The extrinsic pathway is initiated by activation of a group of
cell surface receptors collectively referred to as death receptors
(DDs). In the presence of ligand, trimeric receptor complexes
bind TRADD and/or FADD and, thereby, engage pro-caspase-
8 to form the death-inducing signaling complex (DISC). Cas-
pase-8 undergoes an autocatalytic activating cleavage event in
the DISC and, thereby, initiates the caspase cascade, either indi-
rectly through cleavage of BID and activation of the intrinsic
pathway or directly via direct cleavage and activation of cas-
pases-3,-6, and -7. The intrinsic pathway of apoptosis con-
verges on mitochondria to induce formation of the mitochondrial
permeability transition pore (MPTP) (reviewed in Gillies and Ku-
wana, 2014; Westphal et al., 2014). Bax and Bak play key roles
in the formation of the MPTP, and their activities are normally
suppressed through the action of anti-apoptotic Bcl2 family
members. The task of relieving the Bcl2-dependent suppression
of Bax and Bak is mediated by activation of BH3 domain-only
proteins such as Bid, Bad, and Noxa (reviewed in Happo et al.,Neuron 88, November 4, 2015 ª2015 Elsevier Inc. 461
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the mitochondrion and bind Apaf1, thereby creating the apopto-
some, in which autocatalytic cleavage of caspase-9 allows
executioner caspase activation to proceed.
In Drosophila, the main initiator caspase is the caspase-9 or-
tholog Dronc. Activation of Dronc requires association with
Dark, the Drosophila homolog of Apaf-1, and, in some but not
all tissues, a specific cytochrome c isoform is also required for
Dronc activation (Arama et al., 2006; Dorstyn et al., 2002;
Mendes et al., 2006). Dronc and Apaf1 are mutually suppressive.
When Dronc levels are high, Apaf1 levels are reduced, and when
Apaf1 level are high, Dronc levels are reduced. It has been pro-
posed that thismutually suppressive regulation allows a low level
of apoptosome activity to be generated for use in sublethal con-
texts, after which it is rapidly suppressed (Shapiro et al., 2008).
The fly executioner caspases are reasonably well conserved
with their mammalian counterparts, with Dcp1 and Drice resem-
bling caspase-3, Damm appearing most orthologous to cas-
pase-7, and Decay aligning best with caspase-6 (Steller, 2008).
Sublethal Executioner Caspase Activity in Cellular
Remodeling, Differentiation, and Survival
Initial evidence that executioner caspases play sublethal roles
emerged from an examination of the remodeling events that
drive the loss of cellular material during spermatid individual-
ization inDrosophila. During fly spermatogenesis, syncytial sper-
matids are resolved into sperm through the action of the individ-
ualization complex (IC), a specialized cytoskeletal structure that
depletes spermatid cytoplasm and then encapsulates sperm in
the plasma membrane (Zheng et al., 1999). Individualization
complex function relies on the action of the Apaf-1 homolog
Dark and the fly caspase Dronc, and flies containing mutations
in either of these genes have spermatogenesis defects and
male sterility (Arama et al., 2006; Huh et al., 2004; Rodriguez
et al., 1999). Subsequent studies have demonstrated that
apoptotic caspases also play key roles in several mammalian
cell remodeling events, including the enucleation of erythro-
blasts (Carlile et al., 2004), the terminal differentiation of keratino-
cytes and lens cells (Ishizaki et al., 1998; Lippens et al., 2000;
Yamamoto-Tanaka et al., 2014), and the production of platelet
cells from megakaryocytes (De Botton et al., 2002).
Induction of myogenesis correlates with large increase in cas-
pase-3 and -9 activity (Murray et al., 2008), and myotube forma-
tion is reduced by caspase-3 knockdown in primary myoblasts
derived from caspase-3-null animals (Fernando et al., 2002;
Hunter et al., 2007; Murray et al., 2008). Interestingly, mitochon-
dria do not lose membrane potential or release cytochrome c
during myogenesis, suggesting that caspase-9 and -3 activation
may not require assembly of the apoptosome in this context. An
intriguing feature of myocyte differentiation is the importance of
DNA double-strand breaks (DSBs), which promote the expres-
sion of regulatory genes that drive the differentiation program
(Larsen and Megeney, 2010; Sjakste and Sjakste, 2007). These
DSBs are produced through caspase-dependent cleavage of
iCAD, the inhibitory protein that normally restrains caspase-acti-
vated DNase (CAD) activity. Myocytes depleted of CAD fail to
produce DSBs, and, as a result, myogenic differentiation is
blocked (Larsen et al., 2010). It is intriguing to note that transient462 Neuron 88, November 4, 2015 ª2015 Elsevier Inc.DSBs also accumulate in neurons within multiple brain regions of
rodents exploring novel environments (Suberbielle et al., 2013),
raising the possibility that caspase-dependent iCAD cleavage
may drive gene expression changes in other cellular contexts.
Caspase-3 activity is also required for stem cell differentiation
(Fujita et al., 2008; Janzen et al., 2008), for the production of
pluripotent stem cells from human fibroblasts (Li et al., 2010a),
and for neural stem cell differentiation (Fernando et al., 2005).
In addition to driving DNA double-strand breaks, caspase-3
can cleave and constitutively activate kinases (Fernando et al.,
2002, 2005; Kanuka et al., 2005) or destroy proteins that are
required for the maintenance of self-renewal and pluripotency
(Fujita et al., 2008; Janzen et al., 2008).
Surprisingly, caspase-3 activity can also contribute to cell sur-
vival. Initial results suggesting this showed that neuroprotection
conferred by a preconditioning ischemic event was lost in the
presence of caspase inhibitors (McLaughlin et al., 2003). More
recently, Khalil et al. (2012) have generated compelling genetic
evidence showing that moderate caspase-3 activation results
in cleavage of RasGAP, which, in turn, increases Akt activation
and promotes cell survival. Therefore, mice lacking caspase-3
are defective in Akt activation and display increased cell death
and tissue damage in response to modest levels of cell stress
(Khalil et al., 2012). These counter-intuitive results demonstrate
the diverse activity of the executioner caspases and emphasize
that they cannot simply be considered apoptotic proteases.
Executioner caspases can also affect cellular behavior via
non-cell-autonomous effects (King and Newmark, 2012; Ryoo
andBergmann, 2012). For example, apoptotic cells can generate
mitogens that induce cell division in surrounding cells (Bergmann
and Steller, 2010; Mollereau et al., 2013). This phenomenon has
been established in decapitatedHydra, where caspase activity in
cells at the injury site generates Wnt3, which then induces prolif-
eration of neighboring cells and drives head regeneration (Chera
et al., 2009). Similarly, in Planaria, caspase activity in dying cells
drives production of Wnt family members, which induce stem
cell division and drive regenerative responses in surrounding
cells (Gurley et al., 2010; Pellettieri et al., 2010).
Apoptosis-induced proliferation has also been observed in
mammalian cells where caspase-3 and -7-dependent activation
of phospholipase A2 and the subsequent production of arachi-
donic acid and prostaglandins mediate the proliferation of
neighboring progenitor cells (Li et al., 2010b). Apoptosis can
also exert non-cell-autonomous survival effects. For example,
when Drosophila wing imaginal discs undergo apoptosis, they
release a factor that induces activation of the receptor tyrosine
kinase Tie on neighboring cells. This, in turn, induces an anti-
apoptotic microRNA termed Bantam, making surviving cells
harder to kill (Bilak et al., 2014). Therefore, in an act of cellular
altruism, executioner caspases generate factors that act non-
cell-autonomously to promote proliferation and survival in neigh-
bors while ensuring host cell death.
Turning to the Nervous System: Caspases in Neuronal
Growth and Regeneration
Because the activation, localization, and control of caspase ac-
tivity are regulated tightly, these enzymes are well suited to
mediate local proteolytic events in response to extracellular
Figure 1. Sublethal Caspase Activation Regulates Several Aspects of Neuron Biology
Neuronal activities in which sublethal caspase activity plays a significant role are indicated. Activities shown in blue text indicate caspase functions that represent
normal physiological roles, and those in red indicate roles for sublethal caspase activity after injury or in disease. See text for details.
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cellular consequences of caspase activity are diverse (Figure 1).
In some circumstances, caspases facilitate growth cone forma-
tion and promote pathfinding, whereas, in other situations, cas-
pase activity reduces or even blocks growth.
The first indication that caspase activity plays a significant role
in neuronal growth and pathfinding came from Campbell and
Holt (2003), who found that retinal neurons exposed to netrin-1
or lysophosphatidic acid (LPA) displayed a rapid rise in cas-
pase-3 activity and showed that caspase inhibitors prevented
chemotropic responses to these factors. A physiological role
of sublethal caspase activity in directing retinotectal projections
has been confirmed recently by Campbell and Okamoto (2013).
By imaging caspase activity in vivo, they showed that the Slit-
Robo cascade activates caspase-3 and -9 specifically at retinal
ganglion cell branch points.
The patterning of olfactory sensory neurons also relies on sub-
lethal caspase activity, with caspase-9- or Apaf1-null animals
displaying defects in axonal projection and synapse formation
(Ohsawa et al., 2010). Ohsawa et al. (2010) have also shown
that at least part of this defect reflects reduced cleavage and
release of Semaphorin 7A, a membrane-anchored semaphorin
required for the proper targeting of these projections. Taken
together with recent work showing that caspase-3 activity is
required for NCAM-dependent neurite outgrowth in hippocam-
pal neurons (Westphal et al., 2010), these data suggest that
ligand-receptor systems traditionally associated with path-
finding (Netrin, Slit, Semaphorins) or adhesion (NCAM) mediate
at least part of their effects through sublethal caspase activation,
which, in this context, likely targets cytoskeletal elements with
the growth cone or growing axon.
The early events that occur after axon transection include axon
sealing, retraction, formation of the growth cone, and then axon
extension. Interestingly, in dorsal root sensory neurons trans-ected in vivo, caspase-3 inhibition drastically reduces axon
retraction, prevents growth cone formation, and blocks regener-
ation (O¨ztu¨rk et al., 2013; Verma et al., 2005). Similarly, after laser
transection of sensory or motor axons inCaenorhabditis elegans
lacking CED3 (the worm caspase 3 homolog), growth cone initi-
ation was reduced, and, of the few sprouts produced, most were
defective. This resulted in a dramatic defect in regenerative
outgrowth in CED3-null axons. The authors also found that
calcium transients, calreticulin, and Ced-4 (the worm form of
Apaf1) played key roles in regeneration. Intriguingly, they noted
that Ced-4 has two EF-hand like domains and proposed that
Ca2+ binding to these may induce Ced-4 activation in this setting
(Pinan-Lucarre et al., 2012).
Taken together, these studies show that orthologs of caspase-
3 and -9 play a key role in developmental pathfinding decisions
and regeneration, most likely by acting locally at or near the distal
tip of the neurite. In most cases, caspases seem to have a
positive impact, facilitating turning, growth cone formation, and
neuronal extension. It seems likely that they achieve this by
cleaving regulatory elements that control growth cone and/or
branch point formation and outgrowth dynamics, but this re-
mains to be demonstrated experimentally.
Caspases in Developmental Axon and Dendrite
Degeneration
The facilitation of growth by caspases is contrasted dramatically
by their role in the destruction of axons and dendrites. Unequiv-
ocal evidence for a role of caspases in neurite remodeling
emerged from analyses of the remodeling of Drosophila class
IV dendritic arborization sensory neurons, which produce an
elaborate dendritic arbor in the larval stage that is destroyed dur-
ing morphogenesis. The cell body remains intact and gives rise
to new dendrites that are maintained into maturity (Truman,
1990). The dendritic arbor destruction relies on the activity of
DRONC, which is present in an active form in the dendrite butNeuron 88, November 4, 2015 ª2015 Elsevier Inc. 463
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DIAP1. In this setting, DRONC becomes active only after
DIAP1 is phosphorylated, ubiquitinated, and proteolyzed (Kuo
et al., 2006; Kuranaga et al., 2006; Williams et al., 2006).
The role of caspases in developmental pruning in mammals
has been best studied using NGF-dependent dorsal root sen-
sory neurons (DRGs). In vivo, these neurons extend axons to
the periphery, and those that arrive late or are mistargeted do
not receive adequate NGF and undergo rapid degeneration
(Ernsberger, 2009). This degeneration can be replicated in vitro
simply by plating these neurons in NGF, allowing them to
establish exuberant axons, and then subjecting them to NGF
withdrawal (Unsain et al., 2014). Although early studies using
chemical caspase inhibitors ruled out a role for caspases in
NGF deprivation-induced axonal degeneration (Finn et al.,
2000; Raff et al., 2002), more recent analyses of DRG neurons
derived from mice null for BAX, caspase-9, or caspase-3 have
demonstrated that the intrinsic pathway plays a key role (Niko-
laev et al., 2009; Simon et al., 2012; Unsain et al., 2013). Impor-
tantly, these studies confirmed that chemical caspase inhibitors
had a minor effect on NGF deprivation-induced axonal degener-
ation in CASP3+/+ axons but strongly suppressed generation in
CASP3+/ axons. This suggest that, under normal circum-
stances, the amount of inhibitor that accumulates in axons is
simply too low to block caspase activated upon NGF withdrawal
(Nikolaev et al., 2009; Unsain et al., 2013).
Caspases were reconsidered as effectors of mammalian
axonal degeneration in large part because of a 2009 paper that
indicated that a signaling pathway activated by death receptor
6 (DR6), a TNF receptor superfamily member, induced local cas-
pase activation in DRG axons deprived of NGF (Nikolaev et al.,
2009). The scheme presented indicated that NGF deprivation
activated BACE-dependent cleavage of the amyloid precursor
protein (APP) and that an extracellular fragment of APP gener-
ated by this cleavage functioned as the activating ligand for
DR6 (Nikolaev et al., 2009). As noted above, the notion that cas-
pases play a crucial role in DRG axon degeneration induced by
NGF deprivation has now been repeated bymany labs, but other
elements of this proposed pathway have not stood up to genetic
scrutiny performed by the authors of the original study. Their
subsequent work has shown that animals rendered null for
DR6, APP, or BACE show little or no protection from NGF with-
drawal-induced axon degeneration and that many of the phar-
macological inhibitors and function-blocking antibodies used in
the study by Nikolaev et al. (2009) have protective effects even
on mice rendered null for their molecular targets (Olsen et al.,
2014). Therefore, the activities ascribed to the BACE inhibitors
and function-blocking antibodies against APP or DR6 in Nikolaev
et al. (2009) likely reflect their interaction with alternative targets.
Compartmentalized cultures (Campenot chambers or micro-
fluidic devices) can be used to provide cell bodies with NGF
while examining the local events that occur in distal axons
upon NGF withdrawal. Using this approach with sympathetic
neurons, Cusack et al. (2013) showed that caspase-3 and -9
play essential roles in local axon degeneration induced by NGF
withdrawal, whereas Apaf1 was not required, suggesting that
uncharacterized post-mitochondrial caspase activation path-
ways must be activated in these axons.464 Neuron 88, November 4, 2015 ª2015 Elsevier Inc.The precise role of caspase-6 in axonal degeneration has been
controversial. The 2009 paper by Nikolaev et al. (2009) indicated
that caspase-6 was selectively activated within axons of NGF-
deprived DRG neurons and that caspase-3 was activated only
in cell bodies. However, subsequent genetic and biochemical
analyses have established that caspase-9 and -3 are highly
active in axons of NGF-deprived neurons and that they play
essential and dominant roles in NGFwithdrawal-induced degen-
eration (Cusack et al., 2013; Simon et al., 2012; Unsain et al.,
2013). Interestingly, axons of CASP6/-sympathetic neurons
subjected to ‘‘whole-cell’’ NGFwithdrawal undergo rapid degen-
eration, but, when maintained in compartmented cultures and
subjected to local NGF deprivation, CASP6/ axons are pro-
tected from degeneration (Cusack et al., 2013). Therefore, cas-
pase cascades that are activated by local deprivation can differ
from those activated when the entire cell is subjected to trophic
factor withdrawal. Discerning the specific events that occur in
these settings is certain to provide insights into novel mecha-
nisms that locally activate executioner caspases.
To date, detailed biochemical analyses have been performed
only on NGF-dependent peripheral neurons, but genetic ana-
lyses have suggested that caspases also play an important
role in developmental pruning of central populations. For
example, pruning is defective in projections of retinocollicular
axons to the superior colliculus in both caspase-3 and cas-
pase-6 knockout mice (Simon et al., 2012), and both caspase-
3 and -9 have been implicated in developmental pruning of
olfactory neurons (Cowan and Roskams, 2004; Cowan et al.,
2001). Furthermore, although mechanistic details are lacking,
genetic data indicate that APP and DR6 (but not BACE) play sig-
nificant roles in the regulation of retinocollicular axon pruning
during development and in experience-dependent cortical plas-
ticity (Kallop et al., 2014; Marik et al., 2013; Olsen et al., 2014).
Taken together, these data indicate that executioner caspases
have a fundamental phylogenetically conserved role in axon
and dendrite pruning and raise the possibility that specific,
largely uncharacterized local signaling cascades drive selective
caspase activation events in these settings.
Caspases in Neuronal Plasticity
The hypothesis that caspases may function as modifiers of syn-
aptic plasticity was first advanced after a-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic (AMPA) receptor (AMPAR) sub-
units were identified as substrates for caspase cleavage
(Chan et al., 1999; Lu et al., 2002). Subsequent studies using
pharmacological inhibitors raised the possibility that caspase
activity plays a role in hippocampal long-term potentiation
(LTP) (Gulyaeva et al., 2003; Lu et al., 2006), in long-term sensi-
tization in snails (Bravarenko et al., 2006; Kozyrev et al., 2007),
and in the maintenance of long-term spatial memory in rats
(Dash et al., 2000). In a particularly elegant and thorough study,
Huesmann and Clayton (2006) showed that levels of active cas-
pase-3 were increased post-synaptically in the bird auditory
cortex during song habituation and that caspase blockade pre-
vented acquisition of song-specific memory in the adult zebra
finch.
More recently, caspase-3 activation has been shown to play
an essential role in long-term depression in the hippocampus,
Neuron
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2011; Li et al., 2010c). The activation of caspase-3 that occurred
in this setting appeared to rely on the mitochondrial activation
pathways because mice lacking BAD or BAX were similarly
defective in NMDA receptor-dependent long-term depression
(LTD) (Jiao and Li, 2011). This was a selective effect. Despite a
profound defect in NMDA receptor-dependent LTD, both LTP
and mGluR-LTD were normal in the BAD, BAX, and CASP3
mutants.
There are at least two ways in which caspase-3 activation can
lead to LTD, the first involving a caspase-3, Akt, and GSK3
cascade that contributes to AMPAR internalization. GSK3b ac-
tivity is normally suppressed by Akt, but caspase-3 dependent
cleavage of Akt ablates its kinase activity, freeingGSK3b from in-
hibition. PSD95 can then be phosphorylated directly by GSK3b,
which leads to dispersal of PSD95 clusters and destabilization
of PSD95 within post-synaptic densities (Asselin et al., 2001; Li
et al., 2010c; Nelson et al., 2013; Peineau et al., 2008).
The second involves calcineurin, the calcium-regulatedprotein
phosphatase that is activated by NMDA receptor (NMDAR)-
dependent calcium influx. Calcineurin mediates AMPR de-
phosphorylation and, thereby, facilitatesAMPA receptor internal-
ization (Beattie et al., 2000; Esteban et al., 2003). Interestingly,
calcineurin can also dephosphorylate BAD to promote caspase
activation (Wang et al., 1999), and calcineurin itself can be acti-
vated by caspase-3 cleavage (Mukerjee et al., 2000). Therefore,
it is possible that caspase- and calcineurin-dependent feedfor-
ward mechanisms facilitate the generation of LTD.
Using a proteomics approach, Han et al. (2013) identified
several caspase-3 cleavage substrates in neurons undergoing
apoptotic cell death. One of these was GAP43, a protein well
known for its roles in axonal biology. Surprisingly, GAP43 was
found to be enriched in the post-synapse, and overexpression
of GAP43 mutants resistant to caspase-3 cleavage reduced
NMDA-induced AMPAR endocytosis and blocked LTD (Han
et al., 2013). Several other neuronal caspase-3 substrates iden-
tified in this study have been directly or indirectly linked to synap-
tic biology, raising the possibility that other caspase-dependent
AMPAR internalization routes may exist.
Numerous studies have shown that LTD is associated with
spine shrinkage and elimination (Na¨gerl et al., 2004; Oh et al.,
2013; Zhou et al., 2004), and it is reasonable to predict that these
spine-specific morphological changes are produced by sub-le-
thal caspase activity. This has not yet been demonstrated under
physiological circumstances, but, by inducing local caspase
activity in defined dendritic regions of cultured hippocampal
neurons, Ertu¨rk et al. (2014) induced local spine elimination
and dendritic pruning, consistent with this notion. Interestingly,
this local activation of caspases went on to kill the cell when
endogenous caspase inhibitors were blocked, suggesting that,
under normal circumstances, dendritic caspases must be tightly
controlled to enable local morphological change while prevent-
ing widespread cellular damage.
Stimuli that induce long-term potentiation of synaptic strength
within one population of synapses can induce heterosynaptic
LTD at less active synapses on the same cell (Lo and Poo,
1991; Scanziani et al., 1996). Recent studies have provided
compelling evidence that heterosynaptic plasticity produceschanges in synaptic structure that reflect a competitive balance
between active and inactive synapses (Bourne and Harris, 2011;
Lee et al., 2013). By monitoring the dendritic morphology of indi-
vidual spines at or close to a site of glutamate uncaging, Oh et al.
(2015) established that input-specific synaptic potentiation in-
duces shrinkage and weakening of nearby unstimulated synap-
ses. They rule out the possibility that this local synaptic involution
reflects a competition for limited resources within the dendrite
but provide evidence that the synaptic weakening reflects an ac-
tivity-dependent shrinkage signal produced from spines under-
going potentiation. The nature of the signal(s) produced and
the signaling pathways evoked remain unknown, but it seems
likely that cell surface signaling cascades that induce local cas-
pase activation will emerge as an important mediator of spine
shrinkage.
Initial neuronal activity can alter subsequent synaptic plas-
ticity events through metaplastic changes (Huang et al., 1992).
Recently,Chenet al. (2012) established aparadigm for examining
metaplasticity in vivo, using natural stimuli (patterned or unpat-
terned light) to stimulate tadpole retinal neurons and then exam-
ining the morphology and synaptic activity of tectal projections.
After establishing that patterned stimuli cause LTP, whereas
non-variant ambient light results in LTD, the authors examined
the impact of a metaplastic stimulation (i.e., unpatterned visual
stimuli) on the activity and dendritic structures evoked by subse-
quent patterned or non-variant ambient light. Interestingly, after
metaplastic stimulation, patterned stimuli evoked LTD instead
of LTP, and this switch relied on an NMDA-dependent activation
of caspase-9 and caspase-3/7. MEF2, a transcription factor
that functions as a key regulator of activity-dependent synapse
development, was identified as a caspase target required for
the metaplastic effect (Chen et al., 2012; Dunfield and Haas,
2009). Therefore, caspases can alter synaptic physiology locally
by altering AMPA receptor internalization and spine morphology
and through long-range effects by cleaving transcription factors
that are transported retrogradely to alter gene expression.
Caspases have also been implicated in other forms of synaptic
remodeling, most notably for the removal or dispersal of inactive
synapses at neuromuscular junctions during development. In
developing muscle, acetylcholine receptors (AChRs) form pre-
sumptive clusters before innervation, and those that fail to
associate with neuronal inputs disperse and then disappear
(Moody-Corbett, 1986). Intriguingly, dispersion of the non-inner-
vated AChR clusters is regulated by locally activated caspase-3
(Wang et al., 2014), which acts to cleave disheveled 1 (Dsv1), a
protein that normally associates with MuSK, which acts to pro-
mote AChR clustering. Cleavage of Dsv1 by caspase-3 ablates
its pro-clustering activity, allowing AChR cluster dispersion to
proceed.
Taken together, these data indicate that caspase-9 and -3 play
a key role in synapse modifications and that they use a variety of
context-specific mechanisms to accomplish this. Their targets
include cytoskeletal structural elements, phosphatases, kinases,
and transcription factors in which cleavage can cause gain or
loss of target function. Novel caspase targets involved in synap-
tic changes are emerging, and sorting out precisely who does
what in specific synaptic contexts will be a fascinating challenge
in the coming years.Neuron 88, November 4, 2015 ª2015 Elsevier Inc. 465
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Caspase activity is well suited to drive the major structural mod-
ifications required to produce changes in plasticity. However,
caspases are powerful proteases, and it can be expected that
small changes in their activity can result in pathophysiological
consequences. Consistent with this, several recent studies
have demonstrated that caspase activity can drive synaptic
loss in models of neurodegenerative disease.
More than a century ago, Cajal (1911) proposed that dementia
reflects the weakening of synapses. This concept has been
confirmed in Alzheimer’s disease (AD), where post-mortem
analyses of hippocampi from AD patients have revealed a sub-
stantial decrease in dendritic spine density compared with
age-matched controls (Ferrer et al., 1990), along with early
changes in synaptic function (Ingelsson et al., 2004; Masliah
et al., 1994).
Emerging evidence from animal models examining the roles of
APP in AD pathogenesis strongly suggest that caspase activity
plays a key role driving synaptic defects induced by this protein.
It is clear that the Ab fragment of APP can inhibit hippocampal
LTPand facilitate LTD (Cheng et al., 2009; Kimet al., 2001; Rowan
et al., 2005; Shankar et al., 2008) through activation of a BAX- and
caspase-3-dependent pathway (Chen et al., 2013; Olsen and
Sheng, 2012) and that mice expressing mutant forms of APP
associated with familial AD display increased cleaved caspase-
3 in the post-synaptic compartment, along with reduced spine
density (D’Amelio et al., 2011; Lanz et al., 2003). Importantly,
when these same mice were established in an Apaf1-null back-
ground, they did not showelevated cleavedcaspase-3, andphar-
macological inhibitionof caspase-3activity rescued the reduction
in spine density seen in these animals (D’Amelio et al., 2011).
Several studies have shown that Ab42-induced synaptic
removal of AMPAR relies on the activation of calcineurin (Hsieh
et al., 2006; Wu et al., 2010, 2012; Zhao et al., 2010), and, as
noted above, calcineurin can be activated by caspase cleavage
(Mukerjee et al., 2000). Therefore, it is possible that APP prod-
ucts produced in the Tg2576 strain activate caspase-3-depen-
dent calcineurin cleavage, and, consistent with this, abnormally
high levels of calcineurin proteolytic fragments are observed in
mice expressing mutant forms of APP, and these return to base-
line levels after administration of a pharmacological caspase in-
hibitor (D’Amelio et al., 2011).
Although the generation of LTP is caspase-independent, the
suppression of LTP induced by Ab42 does not occur in cas-
pase-3-null mice (Jo et al., 2011). Furthermore, mice with the
Danish mutation of BRI2/ITM2b, which have increased APP pro-
cessing, display a reduction in LTP that is accompanied by
enhanced caspase-9 activity in synaptic fractions derived from
the hippocampus (Tamayev and D’Adamio, 2012; Tamayev
et al., 2012b). Interestingly, inhibition of caspase-9 activity res-
cues the LTP defect and the progressive memory loss that oc-
curs in these animals (Tamayev et al., 2012a).
Executioner caspase activity has also been implicated in the
neurodegeneration that occurs in Huntington disease (HD). HD
is caused by an expansion of the CAG repeat in the huntingtin
gene (Albin et al., 1990; Vonsattel et al., 1985), and the resulting
mutant protein (mHTT) is a substrate for proteolysis. The genera-
tionof toxicN-terminal fragments frommHTTare thought toplaya466 Neuron 88, November 4, 2015 ª2015 Elsevier Inc.crucial role in the pathogenesis of HD (Gafni et al., 2004; Graham
et al., 2006), and caspase-6 has emerged as an important mHTT
protease. Graham et al. (2006) found that mutation of the cas-
pase-6 cleavage site withinmHTTblocked generation of the toxic
N-terminal fragments, and they and others have found that
YAC128 mice bearing a mutation in the caspase-6 cleavage site
have a delay in disease onset (Graham et al., 2006, 2010, 2012;
Metzler et al., 2010; Milnerwood et al., 2010; Pouladi et al.,
2009). Therefore, cleavage of mHTT at this site (amino acid 586)
is sufficient and required for pathogenesis in mouse models.
Interestingly, cleavage of mHTT at amino acid 586 still occurs
in caspase-6-null animals, albeit at a reduced level (Gafni et al.,
2012; Landles et al., 2012; Wong et al., 2015) and Wong et al.
(2015) have shown that caspase-8 mediates mHTT cleavage un-
der these circumstances. Detailed phenotypic analyses indicate
that some, but not all, HD-like phenotypes are ameliorated in
YAC128 mice lacking caspase-6 (Wong et al., 2015), suggesting
that that toxic mHTT fragments have a dose-dependent effect.
Given this, therapies that specifically target caspase-6 may
have the potential to elicit a partial therapeutic benefit.
Keeping Caspases Sublethal
Executioner caspases can be readily and permanently switched
from an inactive to an active state, are highly processive, and
have a broad target range. Over the last two decades, a wide
array of potential caspase regulators have emerged, but these
regulatory mechanisms do not seem to play a significant role in
regulating apoptosis under physiological circumstances (Galba´n
and Duckett, 2010; Martins et al., 2004; Okada et al., 2002). This
is not surprising because the one circumstance under which the
cell requires unrestrained caspase activity is when it is trying to
rapidly destroy itself. Rather, it seems likely that the major phys-
iological role of the regulatory mechanisms that spatially or
temporally limit caspase activity is to regulate the sublethal cas-
pase activity (Figure 2).
One way to ameliorate the dangerous effects of caspases is
to ensure that activation occurs only when and where it is
required. Mechanisms that allow caspase activation in specific
subcellular compartments are beginning to emerge. One ex-
ample is Tango7, a phylogenetically conserved apoptosome
component that binds DRONC and DARK and directs the
Drosophila apoptosome to the individualization complex, where
sublethal caspase activity is required for sperm individualization
(D’Brot et al., 2013). Another involves the local activation of
Apaf1 and sublethal caspase activity induced by local calcium
fluxes that occur after transection of sensory and motor axons
in Caenorhabditis elegans (Pinan-Lucarre et al., 2012). In other
cases, such as the sublethal activation of caspase-3 that occurs
during LTD, caspase-9 and caspase-3 activation occur only
within specific dendritic spines (Li et al., 2010c). The precise
mechanisms that mediate this local activation remain uncertain,
but Bax-dependent engagement of mitochondria plays a crucial
role in this process (reviewed in Brusco and Haas, 2015).
When an executioner caspase is activated, the cell can draw
upon an array of overlapping mechanisms to reduce its activity
or destroy it. The best characterized cellular caspase inhibitors
are members of the inhibitor of apoptosis (IAP) family. Of the
eight mammalian IAP proteins, XIAP, cIAP1, and cIAP2 have
Figure 2. Regulation of Sublethal Caspase
Activity
Schematic showing distinct pathways that have
been implicated in caspase-9 activation in suble-
thal settings as well as negative regulatory ele-
ments that may facilitate or suppress sublethal
caspase activation. See text for details.
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(Galba´n and Duckett, 2010; Lopez and Meier, 2010; O’Riordan
et al., 2008). These can each bind caspases via their baculovirus
inhibitor of apoptosis protein repeat (BIR) domains, with their
C-terminal RING domain conferring E3 ligase activity (Yang
et al., 2000). All three proteins contain a central ubiquitin-associ-
ated (UBA) domain (Gyrd-Hansen et al., 2008), and cIAP1 and
cIAP2 also contain a caspase activation and recruitment domain
(CARD) that regulates auto-ubiquitination (Lopez et al., 2011).
Drosophila melanogaster has four IAPs, and one of these,
DIAP1, structurally resembles XIAP and potently suppresses
several caspases.
IAPs can directly bind and inhibit caspases, or they can tar-
get caspases for ubiquitination and proteolytic removal. In flies,
DIAP1suppressescaspaseactivity anddevelopmental apoptosis
through the latter mechanism (Goyal et al., 2000; Hawkins et al.,
1999; Lisi et al., 2000; Wilson et al., 2002; Yan et al., 2004).
cIAP1, cIAP2, and XIAP can also target mammalian caspases
for ubiquitination (Choi et al., 2009; Huang et al., 2000; Suzuki
et al., 2001b), but it is not certain whether this mechanism is em-
ployed to remove caspases under physiological circumstances.Neuron 88,Of the mammalian IAPs, only XIAP can
directly block caspase-3, -7, and -9 enzy-
matic activity (Chai et al., 2001;Riedl et al.,
2001; Salvesen and Duckett, 2002; Scott
et al., 2005; Shiozaki et al., 2003; Sun
et al., 1999, 2000; Vaux and Silke, 2005).
It is important to note that IAPs do
not block caspase activation. Rather,
they inhibit activated caspases. This is
because IAPs interact with caspases via
a tetrapeptide motif that is revealed at
the amino terminus of the small caspase
subunit of caspase-3, -7, or -9 after pro-
teolytic processing (Salvesen and Duck-
ett, 2002; Scott et al., 2005). The amino
terminus of the small subunit of caspase-
6 does not contain this IAP-binding motif
and, therefore, cannot bind or be inhibited
by the IAPs (Riedl et al., 2001).
IAPs can regulate sublethal caspase
activity in vivo. As noted above,
Drosophila class IV dendritic arborization
sensory neurons initially produce com-
plex dendritic arbors during pupation
that are subsequently destroyed by the
sublethal activation of DRONC (Kuo
et al., 2006; Williams et al., 2006). Before
morphogenesis, DRONC activity is con-strained through the action of DIAP1. This inhibition is relieved
when IAP is phosphorylated by the kinase IK2, which triggers
its ubiquitination and subsequent proteolysis in the proteasome
(Kuo et al., 2006; Kuranaga et al., 2006; Oshima et al., 2006).
Similarly, XIAP must be removed by proteosomal degradation
for axonal degeneration to proceed in DRG sensory axons that
have been withdrawn from NGF (Unsain et al., 2013). The
pathway driving this event in axons has not been established,
but it is notable that IKKε, the mammalian homolog of IK2, phos-
phorylates XIAP, leading to its ubiquitination and proteasomal
destruction in non-neuronal cells (Kuranaga et al., 2006; Nakhaei
et al., 2012).
A role for IAPs in regulating sublethal caspase activity in syn-
apses has not been established directly, but they are likely to
play a substantive role. Huesmann and Clayton (2006) showed
that IAP overexpression blocked song acquisition in finches
and argued that active caspase-3 is always present in synapses
but is normally sequestered by inhibitors that release a limited
amount of active caspase-3 only for non-sublethal functions.
This implies that synaptic caspase activity is regulated mainly
by tuning caspase inhibition. IAPs seem to play an importantNovember 4, 2015 ª2015 Elsevier Inc. 467
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ity that is normally limited to the dendrite to spread throughout
the neuron and ultimately kill the cell (Ertu¨rk et al., 2014).
IAP transcripts are strongly regulated at transcriptional and
translational levels. cIAP2 mRNA expression is strongly induced
by the canonical and non-canonical nuclear factor kB (NF-kB)
pathways, whereas XIAP mRNA harbors an internal ribosome
entry site (IRES) in its 50 UTR that is utilized during periods of
cellular stress. The Holcik groups (Durie et al., 2011; Thakor
and Holcik, 2012) have studied the regulation of the XIAP IRES
in detail and have shown that, when eIF2a is phosphorylated
and bulk translation is blocked, XIAP is recruited into polysomes
and translated in a cap-independent manner. Because eIF2a
phosphorylation is required for some forms of LTD (Costa-Mat-
tioli et al., 2007), it will be interesting to test whether XIAP pro-
duced via cap-independent IRES translation regulates caspase
activity in dendrites.
Several IAP antagonists have been characterized in mammals
and in Drosophila. SMAC (second mitochondria-derived acti-
vator of caspase; Fulda and Vucic, 2012) and HTRA2 (second
homolog of high temperature requirement-like; Gray et al.,
2000) are produced in the cytosol and then transported into
mitochondria, where they are cleaved to produce N-terminal
neo-epitopes that resemble the IAP binding motifs present in
caspase-3, -7, and -9. Upon MPTP, these are released from
mitochondria and can function as competitive antagonists that
release caspases from their IAP blockade. They can also destroy
their IAP clients, with SMAC inducing IAP auto-ubiquitination
and proteasomal destruction (Galba´n and Duckett, 2010; Yang
and Du, 2004) and HTRA2 utilizing its intrinsic serine protease
activity to cleave the IAPs (Srinivasula et al., 2003; Suzuki
et al., 2001a; Yang et al., 2003).
A similar mechanism of IAP antagonism is employed in
Drosophila. The reaper, hid, and grim (RHG) genes are transcrip-
tionally activated in response to many different proapoptotic
signals, and, when translated, they bind to DIAP1 to induce its
autoubiquitination and proteosomal destruction (Steller, 2008).
Interestingly, although the RHG-DIAP1 pathway plays a crucial
role in regulating developmental and injury-induced apoptosis
in flies, mice rendered null for SMAC, HtrA2, or both do not
display defects in apoptosis during development or in adulthood
(Jones et al., 2003; Martins et al., 2004; Okada et al., 2002).
Although it seems likely that SMAC or HTRA2 will have relevance
for the regulation of caspases in sublethal settings, their involve-
ment remains to be demonstrated experimentally.
ARTS is not structurally or genetically related to the IAPs, but,
nonetheless, it directly binds XIAP and inhibits its anti-apoptotic
activity, apparently by stimulating XIAP autoubiquitination (Gott-
fried et al., 2004; Larisch et al., 2000). Importantly, ARTS-null
mice have elevated XIAP protein levels in some tissues and
display defects in spermatocyte cytoplasm clearing and hair
follicle stem cell apoptosis (Fuchs et al., 2013; Kissel et al.,
2005). Importantly, the defect in hair follicle stem cell apoptosis
inARTS/mice can be rescued in XIAP/mice, demonstrating
that the ARTS-XIAP regulatory loop plays a critical role in regu-
lating caspase-3 in vivo (Fuchs et al., 2013). Whether ARTS reg-
ulates caspases in the nervous system remains unknown, and
this is clearly an interesting topic for future studies.468 Neuron 88, November 4, 2015 ª2015 Elsevier Inc.IAP-independent Caspase Regulatory Mechanisms
Caspases can also be regulated by a range of post-translational
modifications (PTMs). These range from phosphorylation, ubiq-
uitination, and sumoylation to thiol exchange reactions and nitro-
sylation. In several cases, these PTMs have been shown to
have a significant impact on executioner caspase activation
and enzymatic activity. Caspases can also bind divalent cations
or associate with non-IAP protein partners, and these may also
contribute to sublethal caspase regulation.
Direct phosphorylationof caspases canhave amajor impact on
caspase activity. For example, phosphorylation of caspase-9 on
Thr125 or Ser144 blocks its activation in the apoptosome (Brady
et al., 2005; Seifert et al., 2008), whereas phosphorylation of
caspase-6 on Ser257 prevents auto-activation and blocks cas-
pase-3-mediated cleavage (Cao et al., 2012; Suzuki et al., 2004;
Vela´zquez-Delgado and Hardy, 2012a). Recent studies have
examined the consequences of Ser257 phosphorylation in cas-
pase-6 from a structural perspective and determined that phos-
phorylation at this site flips an active site loop with a consequent
1,000-fold reduction in activity (Cao et al., 2012; Vela´zquez-Del-
gadoandHardy,2012a).Thenotion that caspasephosphorylation
mayact as a switch that regulates caspase activity is appealing, in
part because several kinases converge to target active loop sites
(e.g., CDK1, Erk1, Erk1, PKA, DYRK1A, andPKCz caneach target
caspase-9) and because dephosphorylation at these sites can
recover caspase-9 activity (Allan et al., 2003; Brady et al., 2005;
Martin et al., 2005, 2008; Seifert et al., 2008).
Several caspases bind, and are inhibited by, zinc but not
other divalent cations. Of the executioner caspases, zinc inhibi-
tion is strongest for caspase-6 (inhibitory constant [Ki] = 0.3 mM)
and weakest for caspase-3 (Ki = 8.8 mM). The site responsible
for zinc-mediated inhibition has recently been identified in cas-
pase-9 and shown to be comprised of His237, Cys239, and
Cys287, a spaced amino acid triad that spans the caspase
active site and is conserved throughout the caspase family
(Huber and Hardy, 2012; Vela´zquez-Delgado and Hardy,
2012b). In most tissues, zinc ions are trapped within proteins
as structural or catalytic cofactors, but in the hippocampus, cor-
tex, striatum, and amygdala, free zinc is highly enriched in a
subset of glutamatergic neurons through the action of the zinc
transporter ZnT3 (Sensi et al., 2009). Interestingly, zinc has
been implicated in caspase-dependent apoptotic cell death in
the developing brain (Cho et al., 2010), and ZnT3-null mice
show a decrease in neuronal spine density, have defects in syn-
aptic protein levels, and display deficits in learning and memory
(Adlard et al., 2010).
Caspases are cysteine proteases and, as such, are sensitive
to various forms of redox reactions. For example, when the
active cysteine in caspase-3 is S-nitrosylated by nitric oxide,
enzymatic activity is reduced sharply (Liu and Stamler, 1999;
Tenneti et al., 1997). Interestingly, apoptotic stimuli that activate
caspase-3 also lead to its denitrosylation (Mannick et al., 1999),
and recent work has shown that neuronal XIAP is also S-nitrosy-
lated (Tsang et al., 2009). When this occurs, the ability of XIAP to
inhibit caspases is attenuated. This may have physiological rele-
vance because S-nitrosylated XIAP accumulates in neurons
subjected to NMDA excitotoxicity and is prevalent in brains of
patients with AD, Parkinson’s disease and HD (Nakamura
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ated PTMs in the regulation of sublethal caspase control under
physiological and pathophysiological settings will clearly be an
interesting topic for future studies.
Conclusions and Future Directions
Over the last 20 years, themechanisms of apoptosis and the role
of caspases in thisprocess havebeenstudied intensively, andwe
now have a detailed picture of the signaling cascades that
converge to activate these proteases and induce apoptosis. In
addition, numerous studies have demonstrated that executioner
caspases participate in a wide variety of sublethal roles, and
manyof these are critical for normal nervous system function dur-
ing development and in adulthood. We are now beginning to
understand the regulatory constraints that control sublethal cas-
pase activity in normal settings and identify pathophysiological
settings in which these constraints may be reduced or lost.
It is now certain that sublethal caspase activity plays a critical
role in regulating neuronal pathfinding, pruning, and synaptic
plasticity. Emerging data suggest that these crucial pathways
may be subverted in a wide range of nervous system disorders
to promote pathological changes, but our knowledge of the
mechanisms that activate, localize, and suppress this activity
is rudimentary. Learning when, where, and how sublethal execu-
tioner caspase activity controls nervous system function is an
important priority and amajor challenge for future studies. Fortu-
nately, most of the pathways characterized to date are well
conserved across the phylogeny. This suggests that generating
and controlling sublethal caspase activity may be a prerequisite
for the development of a functional nervous system and provides
the means for rapidly generating new insights into the mecha-
nisms that regulate sublethal caspase activity.
Although significant insights have been gleamed from ‘‘grind
and find’’ biochemistry, new findings will be facilitated by the
development of new model systems and tools. Here the future
looks bright because several groups have produced Fo¨rster
resonance energy transfer (FRET)-based biosensors to detect
caspase activity in vitro and in vivo (Ai et al., 2008; Nguyen and
Daugherty, 2005; Takemoto et al., 2003; Xu et al., 1998; Yama-
guchi et al., 2011; Zhou et al., 2010) or developed GFP isoforms
that undergo a dark-to-bright transition in response to caspase-
dependent cleavage (Nicholls et al., 2011). These approaches
have been used mainly to capture caspase activation in the
context of apoptosis but are likely to provide important spatial
and temporal information on sublethal caspase activation, par-
ticularly when they are produced as fusion proteins that allow
them to be localized to specific subcellular compartments
(Figueroa et al., 2011) or to specific caspase substrates. Su-
per-resolution microscopy, proximity ligation assays, and other
emerging techniques will prove to be useful for identifying the
partners that associate with executioner caspases in specific
subcellular locales, and high-resolution proteomics will define
post-translational modifications in caspases that regulate activ-
ity in sublethal settings and will clarify the signaling pathways
that converge to regulate them.
Previously misconstrued as dedicated assassins, it is now
certain that the executioner caspases play important roles in a
wide array of sublethal cellular activities. Our knowledge ofwhen, where, and how their sublethal activities are controlled
within the cell remains rudimentary, but the stage is set for
rapidly expanding our knowledge of this intriguing and therapeu-
tically important area.ACKNOWLEDGMENTS
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